Treatment of initial and recurrent Clostridium difficile colitis
By: Joseph Eskandrous, PharmD Candidate c/o 2019 Clostridium difficile (C. difficile) is a gram-positive, anaerobic, sporogenic bacterium that is primarily…
Food and Drug Administration (FDA) approves baloxavir marboxil (XOFLUZATM): first new flu drug in 20 years
By: Ruchira Kasbekar, PharmD Candidate c/o 2020 It is estimated that approximately 80,000 Americans died from the flu during the…
Targeting biomarkers in immuno-oncology: current agents and its clinical impact
By: Jonathan Mercado (PharmD Candidate c/o 2019), Rebecca Sin (PharmD Candidate c/o 2019) Immuno-oncology is an advanced and rapidly growing…
Fingolimod’s (Gilenya®) expanding role in the treatment of pediatric multiple sclerosis
By: Michael Lim, PharmD Candidate c/o 2020 In 2010, the Food and Drug Administration (FDA) approved fingolimod (Gilenya®) for the…
Food and Drug Administration (FDA) announces additional impurity in valsartan (Diovan®) recall
By: Karen Chen, PharmD Candidate c/o 2019 On July 13th, 2018, the U.S. Food and Drug Administration (FDA) announced a…
Innovation and internet outreach: the Food and Drug Administration’s (FDA) latest tactics in combatting the opioid epidemic
By: Michael Lim, PharmD Candidate c/o 2020 As the nation continues to struggle with the growing opioid epidemic, numerous organizations,…
The importance of medication therapy management (MTM) in pharmacy practice
By: Shivani Shah, PharmD Candidate c/o 2021 Medication therapy management (MTM) is a service provided by pharmacists to eligible patients…
Food and Drug Administration (FDA) warning about biotin interference in laboratory tests
By: Rizwan Atiq, PharmD Candidate c/o 2019 - Biotin is a nutrient that is present in certain foods and is…
Food and Drug Administration (FDA) approves Cassipa®: a new dosage strength sublingual film of buprenorphine and naloxone for maintenance treatment of opioid dependence
By: Maria Spilios, PharmD Candidate c/o 2019 - Opioid dependence is a major public health concern. Misuse of prescription opioids…
Concierge pharmacy practice: RxVIP and your future
By: Lameesa Dhanani, PharmD Candidate c/o 2019 - *Disclaimer: In November 2018, the FDA issued a Safety Communication against changing…